Editor-in-Chief: Godefridus J. Peters
Journal Rank: Impact Factor 2024: 5.2 - Q1 (ONCOLOGY); CiteScore 2024: 8.3 - Q1 [Pharmacology(medical)]
Median time to first editorial decision: 9 days

Cancer Drug Resistance

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN

Articles

Most Recent | Most Viewed | Most Downloaded

Integrating genomic mutations and tumor-infiltrating lymphocytes improves prediction of response to trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer

Open Access Original Article DOI: 10.20517/cdr.2025.133 8 Sep 2025
Views: Downloads:
Download PDF

Targeting the hypoxia signaling pathway with nanomedicine to reverse immunotherapy resistance

Open Access Review DOI: 10.20517/cdr.2025.132 2 Sep 2025
Views: Downloads:
Download PDF

Cryptotanshinone differentially induces cell death in ATP6V0D1-deficient pancreatic cancer cells

Open Access Original Article DOI: 10.20517/cdr.2025.103 27 Aug 2025
Views: Downloads:
Download PDF

Resistance signatures manifested in early drug response across cancer types and species

Open Access Original Article DOI: 10.20517/cdr.2025.112 26 Aug 2025
Views: Downloads:
Download PDF

New advances in understanding the mechanisms and treatment challenges of ALK-targeted therapy resistance in lung cancer

Open Access Review DOI: 10.20517/cdr.2025.122 25 Aug 2025
Views: Downloads:
Download PDF

Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system

Open Access Review DOI: 10.20517/cdr.2023.16 19 Jun 2023
Views: Downloads:
Download PDF

Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects

Open Access Review DOI: 10.20517/cdr.2022.136 28 Apr 2023
Views: Downloads:
Download PDF

Anti-BCMA novel therapies for multiple myeloma

Open Access Review DOI: 10.20517/cdr.2022.138 21 Mar 2023
Views: Downloads:
Download PDF

Coming soon.

For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Articles Collection
Advancing the Fight Against Cancer Drug Resistance Together: Share Your Findings and Enjoy Anniversary Savings!
Marking a 13% rise, CDR continues to lead the field of cancer drug resistance.
This marks a notable 25.8% increase from last year’s score of 6.6, underscoring the CDR’s rising academic impact and global recognition.
We are thrilled to announce that Prof. Baiyong Shen, a globally recognized leader in pancreatic cancer research and Vice President of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, has officially joined Cancer Drug Resistance as an Associate Editor.
The webinar is scheduled for 7th May as an extension of the special issue.
We warmly welcome your participation and contributions.

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN

Coming soon.

Articles Collection
Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/